Romidepsin enhances the efficacy of cytarabine in vivo, revealing histone deacetylase inhibition as a promising therapeutic strategy for KMT2A-rearranged infant acute lymphoblastic leukemia

Laurence C. Cheung, Mark N. Cruickshank, Anastasia M. Hughes, Sajla Singh, Grace-Alyssa Chua, Jette Ford, Emanuela Ferrari, Joyce Oommen, Sebastien Malinge, Richard B. Lock, Ursula R. Kees, Rishi S. Kotecha

Research output: Contribution to journalLetterpeer-review

10 Citations (Scopus)
Original languageEnglish
Pages (from-to)e300-e303
Number of pages4
Issue number7
Publication statusPublished - 30 Jun 2019

Cite this